301 related articles for article (PubMed ID: 23846254)
1. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension.
Sutendra G; Dromparis P; Paulin R; Zervopoulos S; Haromy A; Nagendran J; Michelakis ED
J Mol Med (Berl); 2013 Nov; 91(11):1315-27. PubMed ID: 23846254
[TBL] [Abstract][Full Text] [Related]
2. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
Ryan JJ; Archer SL
Circ Res; 2014 Jun; 115(1):176-88. PubMed ID: 24951766
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
[TBL] [Abstract][Full Text] [Related]
4. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
5. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
Piao L; Fang YH; Parikh K; Ryan JJ; Toth PT; Archer SL
J Mol Med (Berl); 2013 Oct; 91(10):1185-97. PubMed ID: 23794090
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.
Piao L; Fang YH; Cadete VJ; Wietholt C; Urboniene D; Toth PT; Marsboom G; Zhang HJ; Haber I; Rehman J; Lopaschuk GD; Archer SL
J Mol Med (Berl); 2010 Jan; 88(1):47-60. PubMed ID: 19949938
[TBL] [Abstract][Full Text] [Related]
7. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
[TBL] [Abstract][Full Text] [Related]
8. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.
Umar S; Hessel M; Steendijk P; Bax W; Schutte C; Schalij M; van der Wall E; Atsma D; van der Laarse A
Pathol Res Pract; 2007; 203(12):863-72. PubMed ID: 17913382
[TBL] [Abstract][Full Text] [Related]
9. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.
Gomez-Arroyo J; Mizuno S; Szczepanek K; Van Tassell B; Natarajan R; dos Remedios CG; Drake JI; Farkas L; Kraskauskas D; Wijesinghe DS; Chalfant CE; Bigbee J; Abbate A; Lesnefsky EJ; Bogaard HJ; Voelkel NF
Circ Heart Fail; 2013 Jan; 6(1):136-44. PubMed ID: 23152488
[TBL] [Abstract][Full Text] [Related]
10. A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension.
Paulin R; Sutendra G; Gurtu V; Dromparis P; Haromy A; Provencher S; Bonnet S; Michelakis ED
Circ Res; 2015 Jan; 116(1):56-69. PubMed ID: 25287062
[TBL] [Abstract][Full Text] [Related]
11. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
12. The importance of capillary density-stroke work mismatch for right ventricular adaptation to chronic pressure overload.
Noly PE; Haddad F; Arthur-Ataam J; Langer N; Dorfmüller P; Loisel F; Guihaire J; Decante B; Lamrani L; Fadel E; Mercier O
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2070-2079. PubMed ID: 28712579
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial integrity in a neonatal bovine model of right ventricular dysfunction.
Bruns DR; Brown RD; Stenmark KR; Buttrick PM; Walker LA
Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(2):L158-67. PubMed ID: 25416385
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
[TBL] [Abstract][Full Text] [Related]
15. Bawei Chenxiang Wan ameliorates right ventricular hypertrophy in rats with high altitude heart disease by SIRT3-HIF1α-PDK/PDH signaling pathway improving fatty acid and glucose metabolism.
Han Y; Li S; Zhang Z; Ning X; Wu J; Zhang X
BMC Complement Med Ther; 2024 May; 24(1):190. PubMed ID: 38750550
[TBL] [Abstract][Full Text] [Related]
16. Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension.
Zungu-Edmondson M; Shults NV; Wong CM; Suzuki YJ
Cardiovasc Res; 2016 May; 110(1):30-9. PubMed ID: 26790474
[TBL] [Abstract][Full Text] [Related]
17. Effect of p53 activation on experimental right ventricular hypertrophy.
Veeroju S; Mamazhakypov A; Rai N; Kojonazarov B; Nadeau V; Breuils-Bonnet S; Li L; Weissmann N; Rohrbach S; Provencher S; Bonnet S; Seeger W; Schermuly R; Novoyatleva T
PLoS One; 2020; 15(6):e0234872. PubMed ID: 32559203
[TBL] [Abstract][Full Text] [Related]
18. Experimental Right Ventricular Hypertension Induces Regional β1-Integrin-Mediated Transduction of Hypertrophic and Profibrotic Right and Left Ventricular Signaling.
Sun M; Ishii R; Okumura K; Krauszman A; Breitling S; Gomez O; Hinek A; Boo S; Hinz B; Connelly KA; Kuebler WM; Friedberg MK
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29599211
[TBL] [Abstract][Full Text] [Related]
19. Ca
Sabourin J; Boet A; Rucker-Martin C; Lambert M; Gomez AM; Benitah JP; Perros F; Humbert M; Antigny F
J Mol Cell Cardiol; 2018 May; 118():208-224. PubMed ID: 29634917
[TBL] [Abstract][Full Text] [Related]
20. Increased reactive oxygen species, metabolic maladaptation, and autophagy contribute to pulmonary arterial hypertension-induced ventricular hypertrophy and diastolic heart failure.
Rawat DK; Alzoubi A; Gupte R; Chettimada S; Watanabe M; Kahn AG; Okada T; McMurtry IF; Gupte SA
Hypertension; 2014 Dec; 64(6):1266-74. PubMed ID: 25267798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
